Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-18T23:43:05.381Z Has data issue: false hasContentIssue false

Is psychiatry only neurology? Or only abnormal psychology? Déjà vu after 100 years

Published online by Cambridge University Press:  13 November 2014

Jose de Leon*
Affiliation:
University of Kentucky Mental Health Research Center at Eastern State Hospital, Lexington, KY, and Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain, and Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain
*
Dr. Jose de Leon, UK Mental Health Research Center at Eastern State Hospital, 1350 Bull Lea Road, Lexington, KY 40511, USA.Tel: (859) 246-8440; Fax: (859) 246-8446; E-mail: jdeleon@uky.edu
Rights & Permissions [Opens in a new window]

Abstract

Forgetting history, which frequently repeats itself, is a mistake. In General Psychopathology, Jaspers criticised early 20th century psychiatrists, including those who thought psychiatry was only neurology (Wernicke) or only abnormal psychology (Freud), or who did not see the limitations of the medical model in psychiatry (Kraepelin). Jaspers proposed that some psychiatric disorders follow the medical model (Group I), while others are variations of normality (Group III), or comprise schizophrenia and severe mood disorders (Group II). In the early 21st century, the players’ names have changed but the game remains the same. The US NIMH is reprising both Wernicke’s brain mythology and Kraepelin’s marketing promises. The neo-Kraepelinian revolution started at Washington University, became pre-eminent through the DSM-III developed by Spitzer, but reached a dead end with the DSM-5. McHugh, who described four perspectives in psychiatry, is the leading contemporary representative of the Jaspersian diagnostic approach. Other neo-Jaspersians are: Berrios, Wiggins and Schwartz, Ghaemi, Stanghellini, Parnas and Sass. Can psychiatry learn from its mistakes? The current psychiatric language, organised at its three levels, symptoms, syndromes, and disorders, was developed in the 19th century but is obsolete for the 21st century. Scientific advances in Jaspers’ Group III disorders require collaborating with researchers in the social and psychological sciences. Jaspers’ Group II disorders, redefined by the author as schizophrenia, catatonic syndromes, and severe mood disorders, are the core of psychiatry. Scientific advancement in them is not easy because we are not sure how to delineate between and within them correctly.

Type
Perspective
Copyright
© Scandinavian College of Neuropsychopharmacology 2014 

Summations

  • ‘Those who cannot remember the past are condemned to repeat it’ (George Santayana).

  • Jaspers was an inexperienced psychopathologist but a great thinker; rereading Jaspers’ critiques of Wernicke, Freud, and Kraepelin leaves the author with unremitting déjà vu feelings.

  • In the early 21st century, the players’ names have changed but the game remains the same. The US NIMH is reprising both Wernicke’s brain mythology and Kraepelin’s marketing promises, and the US neo-Kraepelinians have reached a dead end with the DSM-5.

Perspectives

  • McHugh, who described four perspectives in psychiatry (1) disease, (2) behaviour, (3) dimensional, and (4) self and life story, is the leading contemporary representative of the neo-Jaspersian diagnostic approach. Others neo-Jaspersians are Berrios, who focused on hybridity of symptoms; Wiggins and Schwartz; Ghaemi; Stanghellini; Parnas and Sass.

  • Psychiatric terminology was developed in the 19th century but is obsolete for 21st century science, and organisationally, includes three levels, symptoms, syndromes, and disorders. Learning from Bech’s understanding of psychometrics and clinimetrics will help psychiatric researchers who are trying to develop contemporary terminology for describing psychiatric symptoms.

  • Advancing knowledge at the core of psychiatry (catatonia, schizophrenia syndromes, and severe mood disorders) is not easy, as these severe mental illnesses lack diagnostic validation methods and clear distinctions between them.

‘Those who cannot remember the past are condemned to repeat it’ (George Santayana).

One hundred years ago

In 1913, a 30-year-old psychiatric trainee named Karl Jaspers, who was studying at the University of Heidelberg, had the arrogance to criticise the scientific status of psychiatry at that time by writing a long and complex book that he called ‘General Psychopathology’ (Reference Jaspers1). This first edition of his book was substantially modified later as the fourth edition, which was finished in 1942 but rejected for publication by Nazi Germany. It was finally published in 1946; minimal changes led to the seventh edition, which was finally translated into English in 1963 (Reference Jaspers2).

Imagine that you are an attending psychiatrist trying to teach your residents about the scientific approach in psychiatry and one of them, a 30-year-old who is not a ‘real resident’ but one doing a voluntary rotation tells you, as Jaspers did, ‘There seems to be no such thing as a common scientific psychiatry uniting all those engaged in psychiatric research. … Psychiatrists must learn to think’ (Reference Jaspers3). How would you respond? Not surprisingly, one of his attendings ‘remarked with a friendly smile’ that ‘Jaspers ought to be spanked’ (Reference Jaspers3). Until the end of his life, Jaspers insisted that psychiatrists must learn to think (Reference López Ibor4).

The qualifications of the arrogant critic of psychiatry in the early 20th century

As dispassionate scientists, let’s try ‘objectively’ to enumerate Jaspers’ qualifications for making such an arrogant critique in 1913. Let’s start with Jaspers’ quantitative qualifications and then move to his qualitative qualifications. When the first edition of his textbook was published, he had worked only 5 years in psychiatry, from 1908 to 1913. Moreover, in his philosophical autobiography he acknowledged that he last worked in a psychiatric hospital in 1915. In the fall of 1913, he took up psychology and started teaching it in the summer of 1914 (Reference Jaspers3). At that time psychology was included in the School of Philosophy. Now his teaching would probably be considered philosophy rather than psychology. After 1915, he never again acted as a psychiatrist. So in 1913 he could claim, at most, 5 years of psychiatric experience and throughout his long life (he lived to age 86) he could claim a maximum of only 7 years of psychiatric practice.

If one wants to assess the quality of Jaspers’ psychiatric practice, his qualifications are further degraded by his inability to handle the physical activities required for being a physician. After many years of illness, he was diagnosed with bronchiectasis and secondary cardiac insufficiency in 1902 when he was 18 years of age. His prognosis was that he would not survive much beyond his 30s. As a matter of fact, Jaspers always considered himself a sick man (Reference Kirkbright5,Reference Häfner6). The upper panel of Table 1 describes how he only worked in psychiatry as ‘as a voluntary assistant’ in research. Although he acted as a psychiatrist, his psychiatric activities were rather limited, as his precisely written description indicates. This description does not match that of a psychiatrist who diagnoses and treats his or her psychiatric patients. But he probably considered himself a psychopathologist rather than a psychiatrist. In the opening passage of the first edition of General Psychopathology (Reference Miron7), Jaspers introduced a distinction between the psychiatrist and the psychopathologist (Table 1, middle panel). So the arrogant critic could claim 5 years of interest in the scientific approach to psychiatry (his definition of a psychopathologist) before the first edition of his textbook, or 7 years over his lifetime.

Table 1 Biographical quotes by Jaspers

Is 5 or 7 years sufficient to grasp psychiatry well enough to produce a coherent critique of it? Again, if you are dealing with an arrogant critic of your psychiatric approach and he has only 5 years of voluntary rotations because he is physically sick and cannot take care of patients, you would probably say no, unless he is ‘a genius’. Was Jaspers a genius? He did not consider himself one (Table 1, lower panel). In the interest of objectivity one has to acknowledge that, if Jaspers was not a genius, certainly he had a powerful mind. He trained as a physician but was able to become a teacher in psychology in 1915 (at 32 years of age) and then in philosophy in 1920 (at 37 years of age), despite having no formal training in these disciplines and not being welcomed by many of the philosophers at the University of Heidelberg (Reference Jaspers3). At the end of his life, he left a long list of philosophy books and a substantial international reputation (Reference Miron7).

Jaspers’ accomplishments are particularly remarkable if one takes into account that for 8 years, during his most productive period, he lived a very difficult life, to the point that he planned to commit suicide with his wife rather than being taken to a concentration camp. This era started at age 53 (in 1937) when he was forced out of the university because he did not want to divorce his Jewish wife. It ended at age 61 (in 1945) when he was reinstated at the University of Heidelberg by the American army and asked to rebuild the Department of Philosophy. During these 8 challenging years, he lived as a recluse in his house with the company of his wife, his books, and his very well-justified fears (Reference Jaspers3,Reference Kirkbright5). A Spanish psychiatrist rotating at Heidelberg for several months testified that he tried to visit Jaspers at his house in 1942 but, despite his interest in seeing Jaspers and expressing admiration for his ideas, Jaspers did not open the door because he did not know him and just briefly talked to him through a peephole in the door of his apartment (Reference Solé Sagarra9). During the Nazi period, Jaspers behaved no doubt as a good and honest human being, which is in contrast with the heavy involvement of other psychiatrists in the sterilisation and euthanasia programmes of psychiatric patients (Reference Strous10), or with his friend, Martin Heidegger, who also became an internationally known philosopher, but aligned himself with Nazi politics at the university and essentially betrayed his teacher and some of his closest friends due to their Jewish ancestry (Reference Ettinger11).

Jaspers’ critiques in the early 20th century

When Jaspers entered psychiatry, academic psychiatry was dominated by a natural science approach, which was true in the Heidelberg department where Kraepelin was chairman from 1891 to 1903 (Reference Fuchs and Herpertz12), although the concept of psychiatry was flexible enough to accommodate Freud’s hermeneutics (Reference Berrios and Marková13).

To be precise about Jaspers’ main contribution to psychiatric science, he proposed that psychiatry is a hybrid discipline requiring two methods, Explaining from the natural sciences and Understanding from the social sciences, which respectively provide an explanation of illness that follows the medical model and an understanding of psychiatric abnormalities that are variations of human living (Reference de Leon14,Reference Berrios15).

Jaspers decided on this hybrid approach to psychiatry after criticising the approaches of two of Meynert’s disciples (Reference Jaspers2). Meynert was a famous neuroanatomist and neuropathologist who was chairman of psychiatry in Vienna at the end of the 19th century. One of his disciples was Wernicke, who became famous at a young age after describing the sensory type of aphasia (Reference Graves16,Reference Lanczik and Keil17). Wernicke thought psychiatry in simplified terms was ‘only neurology’. The other Meynert disciple was Freud, who was initially also interested in aphasia and wrote his first book in 1891, On the Aphasias: a Critical Study (Reference Freud18), but went on to develop psychoanalysis and concluded that psychiatry was ‘only abnormal psychology’.

Jaspers was very critical of Wernicke (Table 2 upper panel) to the point that, in the first edition of his book, he called him a ‘brain mythologist’ (Reference Franzek19) because Wernicke’s only method was Explaining. Jaspers was even more critical of Freud who went to the other extreme: Understanding is the only method needed in psychiatry (Table 2 middle panel).

Table 2 Jaspers’ quotes criticising other psychiatrists

Jaspers was also critical of the medical model of psychiatric illness defended by Kraepelin (Table 2 lower panel). It would be unfair to Kraepelin not to acknowledge some further developments in his career after Jaspers’ critique in 1913. In 1917, Kraepelin opened the German Institute for Psychiatric Research, using the neurosciences of the time to try to improve psychiatric nosology (Reference Kraepelin20). In 1920, in his last article (Reference Kraepelin21,Reference Kraepelin22), Kraepelin acknowledged that his nosological system had failed, and his research programme had failed to provide the neuropathology for dementia praecox and manic-depressive insanity.

Jaspers’ solution in the early 20th century

Jaspers proposed that psychiatric disorders are complex. Some psychiatric disorders follow the traditional medical model; Jaspers called them ‘Group I, known somatic illnesses with psychic disturbances’, with the best example being the general paralysis of the insane. Other psychiatric disorders are not medical disorders but variations of normality (‘Group III’, which Jaspers called disorders of personality). Situated between them are the psychoses (Group II) that, according to Jaspers, can be distinguished from normality but not clearly separated from each other (Reference Jaspers2).

Déjà vu

Rereading Jaspers’ critiques of Wernicke, Freud, and Kraepelin leaves the author with unremitting déjà vu feelings. During the early part of the 21st century he had the same problems with some of his contemporaries that Jaspers had 100 years earlier. Although nobody has extensively elaborated on this concept, this is not a completely original idea. Shorter, in his excellent textbook (Reference Shorter23), A History of Psychiatry, describes the beginning of the 20th century as The End of the First Biological Psychiatry and the current era as The Second Biological Psychiatry. Maj (Reference Maj24), in a recent editorial on General Psychopathology, commented, ‘The most striking analogy is that nowadays, exactly like 1 century ago, the enthusiasm brought about by a period of exceptional progress of research in neurosciences is being followed by some disillusionment, due to the limited relevance of that progress to the elucidation of the pathophysiology of mental disorders. To this disillusionment, the psychiatric field is now reacting in a way that resonates in several respects with Jaspers’ analysis, making a revisitation of his General Psychopathology extremely useful.’ Unfortunately the author’s déjà vu sentiment generalised beyond the subject of biological psychiatry (Reference Shorter23) and disillusionment with it (Reference Maj24). As Table 3 indicates, the names of the players have changed but the game is mostly the same as in the early 20th century.

Table 3 Déjà vu: early 20th (based on General Psychopathology) and early 21st century psychiatry

The 21st century equivalent of Wernicke

The US National Institute of Mental Health (NIMH) has published the Research Domain Criteria (RDoC). According to Insel et al., ‘the RDoC framework conceptualizes mental illness as brain disorders. In contrast to neurological disorders with identifiable lesions, mental disorders can be addressed as disorders of brain circuits’ (Reference Insel, Cuthbert and Garvey25). The RDoC ignore mental disorders that do not fit the concept of a brain disorder. It is not clear whether the RDoC’s developers think such mental disorders do not exist and all mental disorders are brain disorders, or whether some mental disorders which cannot be classified as mental disorders should be of concern for psychiatrists but not for psychiatric researchers (Reference de Leon26). We could use Hyman (Reference Hyman27), the prior NIMH director, who is ‘in sync’ with the RDoC, to clarify this point, ‘Mental disorders are a diverse group of brain disorders that primarily affect emotion, higher cognition and executive function. The boundary between mental and neurological disorders is arbitrary’ (Reference Hyman27). One can conclude that, if Hyman represents what the NIMH really thinks, according to the NIMH, all mental disorders are brain disorders and that the NIMH researchers are the ‘brain mythologists’ of the 21st century. One suspects that there was some outrage from many early 20th century psychiatrists towards Jaspers’ use of the term ‘brain mythologist’ and that this led Jaspers to eliminate the words ‘brain mythologist’ from later editions. In the translated English edition, it appears to be relegated to one place in the Introduction, ‘These anatomical constructions, however, became quite fantastic, (e.g. Meynert, Wernicke) and have rightly been called ‘Brain Mythologies’. (Reference Jaspers2). Anyway, these words are a good label for the RDoC approach. Moreover, when in 2006 Insel and Scolnick (Reference Insel and Scolnick28) proposed to cure mental illness, they were imitating Krapelin’s marketing of a hundred years ago (Reference Kraepelin20). Kraepelin marketed his Institute for Psychiatric Research by describing its goal: ‘to make clear the nature and the sources of mental disturbances, and then to discover ways of preventing them, healing them or making them easier to bear’ (Reference Kraepelin20). Similarly, Insel and Scolnick (Reference Insel and Scolnick28) marketed the NIMH by writing, ‘We now have the research tools necessary. Now is the time for research to set an ambitious goal of finding cures and preventive interventions for these disabling illnesses’. Thus, in the 21st century the US NIMH shares similarities both with Wernicke’s brain mythology and Kraepelin’s marketing promises. So with the passage of time, psychiatric researchers are becoming bolder as they become more ignorant of history.

The 21st century equivalent of Freud

Freud has no counterpart in the 21st century. He was a giant in marketing (Reference de Leon14). His idea of the Unconscious, using a pseudoscientific approach, dominated the literature for a century and only now, is the scientific research on the Unconscious recuperating by means of what psychologists call dual-processing (Reference Evans29), which has not yet reached psychiatry. Although there is no equivalent of Freud in the 21st century, some psychiatrists, such as Aaron Beck and Isaac Marks, have further developed psychological concepts and applied them to the development of specific psychotherapy techniques for specific disorders. These techniques tend to be used more by psychologists and other psychotherapists than by psychiatrists. Moreover, all experts trying to assess the effectiveness of psychotherapy are dealing with unresolved issues pointed out 100 years ago by Jaspers. These include the conceptual difficulty of (1) using psychotherapy as a treatment for bio-medical disorders when it is really as an encounter between human beings, (2) distinguishing the effectiveness of the therapy versus the therapist’s effectiveness, and (3) explaining which processes are responsible for the effectiveness of psychotherapy (Reference Gaudiano and Miller30,Reference Kazdin31). The first attempts to consider the methodological issues involved in integrating psychotherapy and the neurosciences, particularly brain imaging, are occurring (Reference Linden32,Reference Peres and Nasello33).

In conclusion, despite the cyclic nature of history implied in this article, Freud was such a significant and disturbing figure in the early 20th century that no 21st century reincarnation of Freud is possible.

21st century Kraepelinians or neo-Kraepelinians

In 1970 Guze and Robins (Reference Robins and Guze34) presented a programme at Washington University in St Louis to establish the diagnostic validity of a psychiatric illness in five phases: (1) clinical description, (2) laboratory studies, (3) delimitation from other disorders, (4) follow-up studies, and (5) family studies. US psychiatrists are not historically inclined, so it is not surprising that Guze and Robins (Reference Robins and Guze34) did not quote Kraepelin’s textbook but rather, Bleuler’s schizophrenia textbook. When the US psychiatrist Klerman (Reference Klerman35) baptised the Washington University approach as neo-Kraepelinian, he explained that they had been influenced by Kraepelin through the reading of the Mayer-Gross textbook, which transferred the Heidelberg school’s teachings to the United Kingdom (Reference de Leon26). The neo-Kraepelinian revolution was advanced by Spitzer, who forgot about validity and focused on reliability after settling for ‘diagnostic democracy’, which led to the multiplication of psychiatric disorders in the DSM-III (Reference Dean36,Reference Decker37) and the failure to define normal mental health. This historical process finally led to the current dead end of the DSM-5 (Reference de Leon38).

21st century Jaspersians or neo-Jaspersians

The leading follower of the Jaspersian diagnostic approach in the 21st century is McHugh (Table 3), who further elaborated on Jaspers’ heterogeneity by describing four perspectives in psychiatry: (1) disease, (2) behaviour, (3) dimensional, and (4) self and life story (Reference McHugh and Slavney39). In 2005, in a critique of early DSM-5 plans, McHugh explained that, as with medical classifications, DSM-5 should also be arranged around etiopathic clusters (Reference McHugh40).

Jaspers’ General Psychopathology has so many ideas that need to be further developed that it is not surprising the author has found at least three more groups of neo-Jaspersians in the early 21st century (Table 3). The hybridity of all psychiatric objects and a sophisticated elaboration on a model of how psychiatric symptoms can develop have been the themes of Berrios’s latest articles (Reference Marková and Berrios41,Reference Berrios and Markova42). Jaspers’ concept that the research method should fit the type of disorder has been reworked as a ‘multiperspectivalism’ approach by Wiggins and Schwartz (Reference Wiggins and Schwartz43), and as a ‘pluralistic’ approach by Ghaemi (Reference Ghaemi44). Other neo-Jasperians, such as Stanghellini (Reference Stanghellini45) or Parnas and Sass (Reference Nordgaard, Sass and Parnas46,Reference Nordgaard, Revsbech, Saebye and Parnas47) have written on practical issues, including the psychiatric interview.

The qualifications of the arrogant critic of psychiatry in the early 21st century

The author has tried to be a dispassionate scientist and has criticised his hero, Jaspers. He has presented him as an arrogant psychiatric trainee and a 7-year psychopathologist, but also as a persistent and hard-working man who, in spite of his lack of philosophical training, became a renowned international philosopher after surviving with honor one of the darkest times in human history, the Nazi period.

To be fair, Jaspers should have the opportunity to dispassionately criticise the qualifications of this author as a critic of 21st century psychiatry. As Jaspers is dead, the author has to use what Jaspers called Understanding and provide critiques from Jaspers’ point of view. Jaspers would be relieved to know that the author has been given an essentially healthy life which allowed him to start his residency in psychiatry in 1982 (age 23) leading to 32 years of experience (current age 55) in clinical psychiatry, combined with research activities. As books are no longer fashionable in the 21st century, Jaspers would have to use PubMed peer-reviewed articles to assess his scientific production. As of 9 May 2014, Jaspers would have found more than 250 articles in PubMed by the author, the first one in 1985. Jaspers may have observed that until 1996, when the author took his current job, he had 52 articles, of which Jaspers could consider half to be focused on psychopathology, since they discuss psychiatric symptoms. The second most common theme in these 50 articles is pharmacology, which was very underdeveloped in the early 20th century. Jaspers would have been pleased that after 100 years psychiatrists have finally found something to alleviate the suffering of psychiatric patients. However, if he had read a recent editorial by the author, he would have learned that psychiatrists cannot take much credit for the discoveries of psychiatric drugs, since they were mainly a series of serendipitous findings (Reference de Leon48). With the help of current medical students who are computer wizards, Jaspers might have found a recent autobiographical note by the author for his university’s medical student journal (Reference de Leon49). Although Jaspers had a major disagreement with his school principal when he was around 10 years of age, he became a law-abiding citizen but he always challenged authoritarian rules which he could not understand and refused to follow the Nazi request to divorce his Jewish wife (Reference Kirkbright5). Jaspers probably would have concluded that the author became a coward in 1996 when he moved to his current job and decided to stop doing psychopathological research on psychiatric symptoms, which was no longer fashionable in the United States. Moreover, Jaspers might have thought that the author was trying to justify himself in his autobiographical statement (Table 4) and would probably have further commented that the author has tried to run from his prior interest in psychopathology by writing 200 articles in his current job, most of them in pharmacology. The young Jaspers might have labeled him with some disdain ‘a shameful coward’ hiding from the interest in psychopathology he displayed as a young psychiatrist in order to accommodate the establishment in US psychiatry.

Table 4 Biographical quotes by author

Jaspers wrote extensively on the concept of limit situations. According to Jaspers, ‘limit situations are characterised by inevitable antinomies which prevent a person going as usual’ (Reference Mundt50). Jaspers was an ‘aristocratic’ man (Reference López Ibor4) and a shy intellectual academician who had dealt with significant medical problems since childhood; therefore, he would have understood, in this short biographical comment, the author’s withholding of the information that in 2009, he was diagnosed with colon cancer, requiring surgery and chemotherapy. On the other hand, Jaspers would have pointed out that it was necessary to discuss this as a ‘limit situation’ and that it was only fair to discuss the author’s illness as the author, likewise, discussed Jaspers’ illness. Moreover, Jaspers would have wondered if the cancer, as a ‘limit situation’, led the author to question his choice to abandon psychopathology research. Moreover, after reading another article by the author (Reference de Leon14), he would have pointed out that the author’s daughter’s entrance into medical school in August 2013 with plans to study psychiatry was a second limit situation pushing the author to write about the scientific approach in psychiatry (Reference de Leon14,Reference de Leon26,Reference Dean36,Reference de Leon48,Reference de Leon51,Reference de Leon52) and go back to his interest in Jaspers’ writings which he read during his residency before the triumph of the DSM-III in Europe (Reference de Leon51,Reference de Leon52).

Jaspers might conclude that the author’s 32 years of experience in clinical practice appear to be a good first step for offering opinions about 21st century psychiatry. The 250 articles appear to indicate a hard-working man. He would have been kind with the last 200 articles in which the author intruded into the areas of pharmacology, genetics, and statistics, in which he had no training. The lack of philosophical training and reading by the author would probably have been problematic for Jaspers, who thought that his contemporary psychiatrists ‘must learn to think’ (Reference Jaspers3). There is no doubt that early 20th century psychiatrists were much better educated in philosophy and more experienced in philosophical thinking than the author. On the other hand, the author thinks life is profoundly paradoxical. He would like to conclude by describing the paradoxical opinion of Kurt Schneider. There is no doubt that Schneider was a highly reputed and experienced clinician (Reference Hoenig53Reference Janzarik55). He was a great admirer of Jaspers and helped him with the third and following editions of General Psychopathology after Jaspers left his clinical practice (Reference Janzarik55). Schneider’s textbook (Reference Schneider56) helped to simplify and disseminate Jaspers’ ideas among clinical psychiatrists (Reference Hoenig53Reference Janzarik55). Schneider always recommended the first edition of General Psychopathology to his students and thought that the fourth and later editions had too much philosophy (Reference Häfner6,Reference Janzarik55). Thus, Schneider valued the book written by the 30-year-old Jaspers, a young iconoclast with only 5 years of experience in psychopathological research and limited philosophical training, mainly influenced by Max Weber (Reference Kumazaki57). Schneider preferred him to the 59-year-old Jaspers, who was a well-read philosopher heavily influenced by Kant (Reference Miron7). Jaspers finished the fourth edition of General Psychopathology after not engaging in clinical activities for almost 30 years. Early 21st century psychiatry residents appear to agree with Schneider that the English translation of General Psychopathology is too philosophical (Reference de Leon14) and ‘too much’ for their brains. (Or is it too much for their minds?)

Learning from the past

The ambitious goal of this article is to prevent early 22nd century psychiatrists from writing an article comparing their time with ours. What can be learned from these 20th and 21st century psychiatrists and their mistakes?

To answer that question, one must follow Jaspers’ recommendation and ‘learn to think’ even if it requires taking oneself ‘out of the box’ and acknowledging, as McHugh did, that psychiatry is 150 years behind medicine (Reference de Leon38). Moreover, Berrios explained that psychiatry is stuck with 19th century language based on the scientific knowledge of that time (Reference McHugh40). Let’s think critically about psychiatric terminology. To simplify, one can say that it is organised according to three levels: symptoms, syndromes, and disorders. It is really one basic level, symptoms, which can be organised into two superior and competing levels: syndromes and disorders. In the beginning symptoms are arranged according to syndromes, but as knowledge increases, disorders can be defined within the syndromes.

Another important conceptual/organisational issue in psychiatry will result from acknowledging that the DSM-III had an impossible task in serving both the needs of clinicians and researchers. That guaranteed a catastrophe, which has now occurred. The DSM-5 is not helpful for clinicians and the NIMH researchers think that it ‘lacks validity’ (Reference Insel58); the latter believe that the RDoC alternative is the way to go (Reference Insel, Cuthbert and Garvey25). The remainder of this article attempts to suggest a research agenda for the future of psychiatry. The recommendations for practicing clinicians are described in Table 5 (Reference Guy and Ban59Reference de Leon, Chambers and Hyatt71).

Table 5 Recommendations for current clinicians and the training of future psychiatrists

* Association for Methodology and Documentation in Psychiatry (AMDP), originally called Arbeitsgemenschaft fur Methodic und Dokumentation in der Psychiatrie.

The Andreasen scales are called Scale for the Assessment of Negative Symptoms (SANS) (Reference Carroll, Kirkhart and Ahuja60) and Scale for the Assessment of Positive Symptoms (SAPS) (Reference Andreasen61). Using factor analyses, Andreasen and others describe schizophrenia symptoms as more properly classified in three dimensions: positive, disorganised, and negative. No official modification of these scales has been made, which would permit classification in three dimensions but some studies have used them (Reference Andreasen62).

The Liverpool ADR scale helps establish causality, the relationship between medication and an ADR.

§ AIMS: Abnormal Involuntary Movement Scale (Reference Gallagher, Kirkham and Mason68).

NRS: Neurological Rating Scale (Reference Guy69).

The language of psychiatric symptoms appears to have been carved in stone in the 19th century. The humongous problem is that DSM-III tried to establish good inter-rater reliability at the disorder level without first dealing with the symptom level (Reference de Leon14). As Berrios indicated, it is very important to create a new language for describing psychiatric symptoms using 21st century knowledge (Reference Berrios and Markova42). Learning from Bech’s understanding of psychometrics (Reference Bech72) and clinimetrics (Reference Tomba and Bech73) will not hurt psychiatric researchers who are trying to develop contemporary psychiatric terminology to describe symptoms.

During his lifetime (Reference Hoche, Dening and Dening74,Reference Berrios and Dening75), Kraepelin was criticised for thinking he was going from symptoms to disorders when he was going from symptoms to syndromes. Unfortunately, even today psychiatry cannot aspire to designate psychiatric disorders; only syndromes can be defined for Jaspers’ Groups II and III disorders. Psychiatric syndromes are very important because they are used by clinicians to select treatments (Table 5).

Before commenting on the disorder level, the author has to make a painful statement of fact. Psychiatry overlaps with neurology; it is not the same as neurology, but it appears to lose disorders to neurology. Neurologists usually lack the flexibility and knowledge to use what Jaspers calls Understanding in their diagnostic schemes. However, once the neuropathology of a psychiatric disorder is well established, the natural historical process is that the disorder moves from psychiatry to neurology. In Jaspers’ time epilepsy was a psychiatric disorder. As a matter of fact, epilepsy is listed by Jaspers in his Group II with schizophrenia and manic-depressive illnesses, although in the 21st century there is no doubt that epilepsy is a neurological disorder. Some of the most difficult epileptic patients have such a strong ‘psychiatric’ component in the diagnosis and treatment that most common sense neurologists ask psychiatrists with expertise in that area for help. This perspective comment cannot extensively review the situation of Alzheimer disease but it has been briefly reviewed elsewhere (Reference de Leon76). In Jaspers’ day, Alzheimer disease was a psychiatric disorder since psychiatric researchers such as Alzheimer were both psychiatrists and neuropathologists. Psychiatrists no longer have neuropathological expertise, so the research on dementing disorders is increasingly conducted by neurologists (Reference de Leon76). Psychiatrists usually lack the skill and knowledge to diagnose dementing illnesses as capably as neurologists. Ask a psychiatrist what hippocampal sclerosing of ageing is (Reference Nelson, Smith and Abner77).

For discussing the disorder level, the author is going to use Jaspers’ classification system. For Group I, called organic mental disorders in the DSM-III, research in the neurosciences is fundamental. Unfortunately, the riddle of Alzheimer disease appears much more complex to solve than expected (Reference de Leon76). We now know that brain mechanisms are extraordinarily complex and our models have been too simplistic. The author suspects that dementing illnesses may not be part of psychiatry in the early 22nd century; they will probably be part of neurology.

Scientific advances directed towards variants of normality (Jaspers’ Group III disorders) are difficult because of the need to challenge preconceived ideas. An excellent example of using fruitful new ideas to redefine preconceptions is occurring in psychosomatic medicine through the efforts of Fava et al. (Reference Fava, Sonino and Wise78). Collaboration with researchers in the social and psychological sciences is fundamental in better defining and investigating these disorders/abnormalities (Reference Van Os79). A very significant linguistic problem is that most of the practical language in psychiatry in the area of Understanding or interpretations is contaminated by19th century Freudian ideology. The author thinks that concepts such as defense mechanism are very helpful for clinicians but they need to be reformulated, taking into account what we know about the brain’s dual-processing mechanisms, and systematically investigated in the clinical environment as much as possible, rather than being derived from psychoanalytic theory; psychoanalysis is a pseudoscience (Reference de Leon14). As a matter of fact, many of these ideas and terms were taken by Freud from prior thinkers (Reference Ellenberger80) and need to be rescued from Freudian ideology. After seeing the limitations of traditional physics in dealing with microcosms and macrocosms in the 20th century, we need to acknowledge that our scientific methods were developed and perfected in the natural sciences by dealing with physical objects, but most subjective human phenomena cannot be approached the same way.

Jaspers’ Group II is the core of psychiatry, usually called severe mental illness, which affects ~5% of the population of developed countries (Reference de Leon48). In the view of the author, severe mental illness includes the catatonia syndrome, the schizophrenia syndrome and the severe mood disorders (bipolar disorders and severe cases of depression). They are the core of the ‘business’ of psychiatry from the point of view of treatment (Table 5). Research in Group II disorders is very challenging; neuroscientists may help but they cannot crack the codes since we are not sure how to distinguish these disorders correctly among themselves, as Jaspers described. They are really syndromes. As a matter of fact, the author doubts that the diagnosis of schizophrenia will exist in the early 22nd century; moreover, it was probably an accident of history that Kraepelin joined together such a heterogeneous group of disorders and separated them from the manic-depressive illnesses. Testing non-Kraepelinian models may be a good idea. The author likes the 20th century Leonhard’s model of classifying psychoses (Reference de Leon76), which has mainly been ignored by US psychiatry. However, building new 21st century models may be required.

In the last few years, there has been huge spending on psychiatric genetics with the promise that this may bring about miraculous advances; these studies have been supported to the detriment of clinically relevant research. In one of the few critical reviews of these expenses, Sadler (Reference Sadler81) has estimated that these studies may have taken from 4% to 8% of the NIH expenditures for three psychiatric illnesses during the reviewed years of 2008 and 2009. It is likely that the most recent genome-wide association studies were even more costly, but demonstrated only what Jaspers proposed, that there is no clear delimitation between schizophrenia and severe mood disorders since they demonstrate substantial genetic overlap. Moreover, substantial overlap exists in genes associated with schizophrenia, severe mood disorders and even autism. Therefore, it is not clear how or when these genetic findings can contribute to the challenging process of developing new psychiatric medications (Reference Muglia82). In 2013, a new brain imaging initiative was launched in the United States, which will take money from the National Institutes committed to psychiatric research (Reference Insel, Landis and Collins83). These Institutes budgets had already been cut in recent years and are only able to provide funding for a very small percentage of submitted grants, canceling the future development of new US psychiatric researchers. This investment in brain imaging occurs despite the clinically unreliable results provided by psychiatric imaging methods (Reference Borgwardt, Radua and Mechelli84) and the improbability that they can speed the development of new psychiatric treatments (Reference Poo85).

Conclusion

This perspective proposes that forgetting history is a mistake since it frequently repeats itself in a somewhat modified way. In General Psychopathology, Jaspers criticised early 20th century psychiatrists including Wernicke, the ‘brain mythologist’ who thought psychiatry was only neurology. Jaspers criticised Freud, who confused meaningful connections with causal connections and thought that psychiatry was only abnormal psychology. Jaspers criticised Kraepelin, who did not see the limitations of the medical model in psychiatry. Jaspers proposed that psychiatric disorders are complex, and include a few that follow the medical model, others which are variations of normality and, situated between them, schizophrenia and severe mood disorders.

In the early 21st century, the names of the players have changed but the game remains fundamentally the same as 100 years ago (Table 3). The US NIMH is exercising the privilege of reprising both Wernicke’s brain mythology and Kraepelin’s marketing promises, indicating that psychiatric researchers are becoming bolder as they become more ignorant of history. Research psychologists are more humble (Reference Evans29), but are still recuperating from the deleterious effects of Freud, the great marketer. The neo-Kraepelinian revolution started at Washington University, was catapulted to the forefront by Spitzer with the DSM-III, and appears to have reached a dead end with the DSM-5. The leading follower of the Jaspersian diagnostic approach in the 21st century is McHugh, who described four perspectives in psychiatry: (1) disease, (2) behaviour, (3) dimensional, and (4) self and life story. Another 21st century Jaspersian is Berrios, who expanded on the hybridity of all psychiatric objects and elaborated on a model describing how psychiatric symptoms can develop. Jaspers’ concept that the research method should fit the type of disorder has been reworked as a ‘multiperspectivalism’ approach by Wiggins and Schwartz, and as a ‘pluralistic’ approach by Ghaemi. Other neo-Jaspersians, such as Stanghellini or Parnas and Sass, have written about practical issues including the psychiatric interview.

The paradox of this story is that the loyal Kurt Schneider preferred the ideas of the 30-year-old Jaspers, a young iconoclast with only 5 years of experience in psychopathological research and limited philosophical training, rather than the 59-year-old Jaspers, a well-read philosopher who wrote a too-philosophical General Psychopathology, which is the version that has been translated into English, to the dismay of psychiatric residents in the 21st century who can barely understand it.

Can psychiatry learn from its mistakes? Perhaps not, since that requires humility and some bitter medicine. Psychiatric language, at its three levels, symptoms, syndromes, and disorders, is really one basic level, symptoms, which can be organised into two superior and competing levels: syndromes and disorders. In the beginning symptoms are arranged according to syndromes but, as knowledge increases, disorders can be defined within the syndromes. This psychiatric language was developed by 19th century thinkers, but we inhabit the 21st century. Nineteenth-century terms are somewhat helpful for clinicians, but are not sufficient for 21st century science. The first step towards a more scientifically valid psychiatry is to acknowledge that we must agree on the first level of psychiatric terminology and develop appropriate inter-rater reliability at the level of psychiatric symptoms. Reading Berrios (Reference Marková and Berrios41,Reference Berrios and Markova42) and Bech (Reference Bech72,Reference Tomba and Bech73) may be helpful.

Clinicians appear to be treating patients using a syndromic approach (Reference Dean66). It appears to be better to drop any attempt to develop DSM-6 and move to a simpler system for diagnosing patients. In the author’s opinion, McHugh (Reference McHugh and Slavney39,Reference McHugh40) offers the best approach.

Scientific advances in what Jaspers called Group I disorders appear to transfer disorders to the field of neurology, since psychiatrists no longer have expertise in neuropathology. Scientific advances in what Jaspers called Group III disorders, variations of normality, require collaborating with researchers in the social and psychological sciences. There is a huge practical need to rescue the language of Understanding or interpretation from Freudian ideology. Jaspers’ Group II disorders (the catatonia and schizophrenia syndromes and the severe mood disorders) are the core of psychiatry and affect ~5% of the population of developed countries. The author thinks that scientific advancement regarding these is not easy because we are not sure how to delineate between them correctly, as Jaspers described. There are no gold standards such as neuropathology to validate them. Non-Kraepelinian models need to be tested. Among neo-Kraepelinian models, testing the Leonhard model of psychoses is relatively simple, once there is the willingness to do it (Reference de Leon76). Developing new non-Kraepelinian models that aspire to have validity appears to be a very complicated task, since genetic overlap of schizophrenia and severe mood disorders indicate, as Jaspers described, that there is no clear boundary between them. As far as the author can predict, a specific and valid narrowly defined psychiatric illness may include some patients who are currently included in schizophrenia and others who are included in the severe mood disorders. As both genetic and clinical findings indicate patient overlap, even using complex statistical techniques may not help to separate them since statistical techniques do not appear to help medical nosology. Oncology is progressing by using tissue findings to link mechanisms and genes, but this not an option in psychiatry. The author proposes three ideas that may help to clarify the field: (1) It is important to separate entities that may have different physiopathological mechanisms, in the sense that patients with catatonic syndromes may need to be studied separately from patients with schizophrenia, severe mood disorder or autism who have never presented catatonic syndromes; (2) non-familial forms of psychiatric disorders may not necessarily have the same genetic and/or environmental loading as familial forms and (3) careful studies of families with high loading of severe mental illnesses using sophisticated new thinking are needed. The last two ideas come from Alzheimer disease research. Alzheimer disease appears to be a group of illnesses sharing a common neuropathology and include a complex mix of some familial forms with very specific genes with heavy genetic loading and others that appear to reflect complex gene-environmental interactions. It is possible that studying familial forms may help to segregate a few patients from the continuum between schizophrenia and severe mood disorders, but these small new nosological categories may tell little about the remaining patients unless we hit the lottery and they help us discover something about specific brain mechanisms that can provide some clues about other brain mechanisms in other familial and non-familial forms of schizophrenia and severe mood disorders.

Acknowledgements

The author acknowledges Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article. In his e-mails to the author, Prof. Dr. Heinz Häfner provided helpful clarifications to the author about the relationship between Karl Jaspers and Kurt Schneider.

Financial Support

This article received no specific grant from any funding agency, commercial business, or not-for-profit institution.

Statement of interest

Dr. de Leon personally develops his presentations for lecturing, has never lectured using any pharmaceutical or pharmacogenetic company presentation, and has never been a paid consultant for pharmacogenetic or pharmaceutical companies. In the past, Dr. de Leon has received researcher-initiated grants from Eli Lilly (one ended in 2003 and the other, as co-investigator, ended in 2007), from Roche Molecular Systems Inc. (ended in 2007) and, in a collaboration with Genomas Inc., from the NIH Small Business Innovation Research programme (ended in 2010). He was on the advisory boards of Bristol-Myers Squibb (2003/2004) and AstraZeneca (2003). Roche Molecular Systems supported one of his educational presentations, which was published in a peer-reviewed journal (2005). His lectures have been supported once by Sandoz (1997), twice by Lundbeck (1999 and 1999), twice by Pfizer (2001 and 2001), three times by Eli Lilly (2003, 2006, and 2006), twice by Janssen (2000 and 2006), once by Bristol-Myers Squibb (2006), and seven times by Roche Molecular Systems Inc. (once in 2005 and six times in 2006).

References

1. Jaspers, K. Allgemeine Psychopathologie. Bin leitfaden fur studierende, arzte und Psychologen, 1st edn. Berlin: Springer, 1913.Google Scholar
2. Jaspers, K. General Psychopathology Translated from the German 7th edition by Hoenig J and Hamilton MH) Manchester, UK: Manchester University Press, 1963.Google Scholar
3. Jaspers, K. Philosophical autobiography. In Schilpp PA editor The Philosophy of Karl Jaspers. La Salle, IL: Open Court Publishing Co, 1957: 594 Google Scholar
4. López Ibor, JJ. 100th anniversary of the birth of Karl Jaspers. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1982;10:321330.Google Scholar
5. Kirkbright, S. Karl Jaspers: A Biography. Navigations in Truth. New Haven, CT: Yale University Press, 2004.Google Scholar
6. Häfner, H. Karl Jaspers. 100 years of ‘Allgemeine Psychopathologie’ (General Psychopathology). Nervenarzt 2013;84 1281–1282, 1284–1286 12881290.Google Scholar
7. Miron, R. Karl Jaspers from Selfhood to Being. Amsterdam/New York: Rodopi, 2012.Google Scholar
8. Jaspers, K. A self-portrait. In: Ehrlich LH, Wisser R, editors. Karl Jaspers Today: Philosophy at the Threshold of the Future. Washington, DC: Center for Advanced Research in Phenomenology & University Press of America, 1988: 125.Google Scholar
9. Solé Sagarra, J. Historia vivida de la psiquiatría: 1940–1945. IMP-Psiquiatría 1990;2:1114.Google Scholar
10. Strous, RD. Hitler’s psychiatrists: healers and researchers turned executioners and its relevance today. Harv Rev Psychiatry 2006;14:3037.Google Scholar
11. Ettinger, E. Hannah Arendt. Martin Heidegger. New Haven, CT: Yale University Press, 1995.Google Scholar
12. Fuchs, T, Herpertz, S. The centennial of Karl Jaspers’. Psychopathology 2013;46:279280.Google Scholar
13. Berrios, GE, Marková, IS. Assessment and measurement in neuropsychiatry: a conceptual history. Semin Clin Neuropsychiatry 2002;7:310.CrossRefGoogle ScholarPubMed
14. de Leon, J. Is psychiatry scientific? A letter to a 21st century psychiatry resident. Psychiatry Investig 2013;10:205217.Google Scholar
15. Berrios, GE. Jaspers and the first edition of Allgemeine Psychopathologie. Br J Psychiatry 2013;202:433.Google Scholar
16. Graves, RE. The legacy of the Wernicke-Lichtheim model. J Hist Neurosci 1997;6:320.Google Scholar
17. Lanczik, M, Keil, G. Carl Wernicke’s localization theory and its significance for the development of scientific psychiatry. Hist Psychiatry 1991;2:171180.Google Scholar
18. Freud, S. On the Aphasias: A Critical Study (Translated by Stengel E.) New York: International University Press, 1953.Google Scholar
19. Franzek, E. Influence of Carl Wernicke on Karl Leonhard’s nosology. Psychopathology 1990;23:277281.Google Scholar
20. Kraepelin, E. The German institute of psychiatric research. J Nerv Ment Dis 1920;51:505513.Google Scholar
21. Kraepelin, E. Die Erscheinungsformen des Irreseins. Z Gesamte Neurol Psychiatr 1920;62:129. (Translated in 1992).Google Scholar
22. Kraepelin, E. The manifestations of insanity. Hist Psychiatry 1992;4:509529.Google Scholar
23. Shorter, E. A History of Psychiatry. From the Era of the Asylum to the Age of Prozac. New York: John Wiley & Sons Inc., 1997.Google Scholar
24. Maj, M. Mental disorders as ‘brain diseases and Jaspers’ legacy. World Psychiatry 2013;12:13.Google Scholar
25. Insel, T, Cuthbert, B, Garvey, M et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010;167:748751.Google Scholar
26. de Leon, J. One hundred years of limited impact of Jaspers’s general psychiatry on US psychiatry. J Nerv Ment Dis 2014;202:7987.Google Scholar
27. Hyman, SE. Can neuroscience be integrated into the DSM-V? Nature Rev Neurosci 2007;8:725732.Google Scholar
28. Insel, TR, Scolnick, EM. Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol Psychiatry 2006;11:1117.Google Scholar
29. Evans, JS. Dual-processing accounts of reasoning, judgment, and social cognition. Annu Rev Psychol 2008;59:255278.Google Scholar
30. Gaudiano, BA, Miller, IW. The evidence-based practice of psychotherapy: facing the challenges that lie ahead. Clin Psychol Rev 2013;33:813824.Google Scholar
31. Kazdin, AE. Understanding how and why psychotherapy leads to change. Psychother Res 2009;19:418428.Google Scholar
32. Linden, DE. Brain imaging and psychotherapy: methodological considerations and practical implications. Eur Arch Psychiatry Clin Neurosci 2008;258(Suppl. 5):7175.Google Scholar
33. Peres, J, Nasello, AG. Psychotherapy and neuroscience: towards closer integration. Int J Psychol 2008;43:943957.Google Scholar
34. Robins, E, Guze, SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970;126:983987.Google Scholar
35. Klerman, GL. The evolution of a scientific nosology. In Shershow JC, editor. Schizophrenia: Science and Practice. Cambridge, MA: Harvard University Press, 1978: 99121.Google Scholar
36. Dean, CE. The death of specificity in psychiatry: cheers or tears? Perspect Biol Med 2012;55:443460.Google Scholar
37. Decker, HS. How Kraepelinian was Kraepelin? How Kraepelinian are the neo-Kraepelinians? –from Emil Kraepelin to DSM-III. Hist Psychiatry 2007;18:337360.Google Scholar
38. de Leon, J. DSM-5 and research domain criteria: one hundred years after Jaspers’s general psychopathology. Am J Psychiatry 2014;17:492494.Google Scholar
39. McHugh, P, Slavney, PR. The Perspectives of Psychiatry, 2nd edn. Baltimore, MD: The Johns Hopkins University Press, 1998.Google Scholar
40. McHugh, PR. Striving for coherence: psychiatry’s efforts over classification. JAMA 2005;293:25262528.Google Scholar
41. Marková, IS, Berrios, GE. Epistemology of mental symptoms. Psychopathology 2009;42:343349.Google Scholar
42. Berrios, GE, Markova, IS. Symptoms – historical perspective and effect on diagnosis. In Blumenfield M, Strain JJ, editors. Psychosomatic medicine. Philadelphia, PA: Lippincott Williams & Wilkins, 2006. p. 2738.Google Scholar
43. Wiggins, OP, Schwartz, MA. Karl Jaspers’ multiperspectivalism. Psychopathology 2013;46:289294.Google Scholar
44. Ghaemi, SN. Pluralism in psychiatry: Karl Jaspers on science. Phil Psychiatry Psychol 2007;14:3766.Google Scholar
45. Stanghellini, G. The grammar of the psychiatric interview. A plea for the second-person mode of understanding. Psychopathology 2007;40:6974.Google Scholar
46. Nordgaard, J, Sass, LA, Parnas, J. The psychiatric interview: validity, structure, and subjectivity. Eur Arch Psychiatry Clin Neurosci 2013;263:353364.Google Scholar
47. Nordgaard, J, Revsbech, R, Saebye, D, Parnas, J. Assessing the diagnostic validity of a structured psychiatric interview in a first-admission hospital sample. World Psychiatry 2012;11:181185.Google Scholar
48. de Leon, J. Paradoxes of US psychopharmacology practice in 2013: undertreatment of severe mental illness and overtreatment of minor psychiatric problems. J Clin Psychopharmacol 2014;34:545548.Google Scholar
49. de Leon, J. Get ready to become ignorant with age: letter to James. The Other Side (A University of Kentucky Literary Magazine) 2014;3:1415.Google Scholar
50. Mundt, C. Jaspers concept of ‘limit situation’: extensions and therapeutic applications. In Fuchs T, Breyer T, Mundt C, editors. Karl Jaspers philosophy and psychopathology. New York, NY: Springer, 2014:169178.Google Scholar
51. de Leon, J. A post-DSM-III wake-up call to European psychiatry. Acta Psychiatrica Scandinavica 2014;129:7677.Google Scholar
52. de Leon, J. Is it time to wake up Sleeping Beauty? European psychiatry has been sleeping since 1980. Rev Psiquiatr Salud 2014; pii:S1888-9891(14)00002-0. doi:10.1016/j.rpsm.2013.12.004. [Epub ahead of print].Google Scholar
53. Hoenig, J. Kurt Schneider and Anglophone psychiatry. Compr Psychiatry 1982;23:391400.Google Scholar
54. Huber, G. Kurt Schneider: the man and his scientific work. Zentralblatt Neurol Psychiatr 1987;246:177191.Google Scholar
55. Janzarik, W. Jaspers, Kurt Schneider and the Heidelberg school of psychiatry. Hist Psychiatry 1998;9:241252.Google Scholar
56. Schneider, K. Clinical Psychopathology. London, UK: Grune & Stratten, 1959.Google Scholar
57. Kumazaki, T. The theoretical root of Karl Jaspers’ general psychopathology. Part 2: the influence of Max Weber. Hist Psychiatry 2013;24:259273.Google Scholar
58. Insel, T. Director’s Blog: transforming diagnosis. April 29, 2013. Available at http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml. Accessed September 10, 2014.Google Scholar
59. Guy, W, Ban, TA. The AMDP-System. Heidelberg, Germany: Springer, 1982.Google Scholar
60. Carroll, BT, Kirkhart, R, Ahuja, N et al. Katatonia: a new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont) 2008;5:4250.Google Scholar
61. Andreasen, NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1983.Google Scholar
62. Andreasen, NC Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa, 1983.Google Scholar
63. Pelayo-Terán, JM, Diaz, FJ, Pérez-Iglesias, R et al. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis. Psychol Med 2014;44:3750.Google Scholar
64. Bech, P. Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton. Psychother Psychosom 2009;78:202211.Google Scholar
65. Young, RC, Biggs, JT, Ziegler, VE et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429435.Google Scholar
66. Dean, CE. The death of specificity in psychiatry. Cheers or tears? Persp Biol Med 2012;55:443460.Google Scholar
67. de Leon, J. The future (or lack of future) of personalized prescription in psychiatry. Pharmacol Res 2009;59:8189.Google Scholar
68. Gallagher, RM, Kirkham, JJ, Mason, JR et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One 2011;6:e28096.Google Scholar
69. Guy, W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: U.S. Department of Health, Education, and Welfare, 1976.Google Scholar
70. Simpson, GM, Angus, JWS. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 1970;212(Suppl.):1119.Google Scholar
71. de Leon, J, Chambers, A, Hyatt, M et al. A Practitioner’s Guide for Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. New York, NY: Springer Verlag, 2012.Google Scholar
72. Bech, P. Clinical Psychometrics. Chichester, West Sussex: Wiley-Blackwell, 2012.Google Scholar
73. Tomba, E, Bech, P. Clinimetrics and clinical psychometrics: macro- and micro-analysis. Psychother Psychosom 2012;81:333343.Google Scholar
74. Hoche, A, Dening, RG, Dening, TR et al. The significance of symptom complexes in psychiatry. Hist Psychiatry 1991;2:329343.Google Scholar
75. Berrios, G, Dening, T. Alfred Hoche and DSM-III-R. Biol Psychiatry 1991;29:9395.Google Scholar
76. de Leon, J. Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalized medicine in psychiatry. Acta Neuropsychiatrica (in press).Google Scholar
77. Nelson, PT, Smith, CD, Abner, EL et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 2013;126:161177.Google Scholar
78. Fava, GA, Sonino, N, Wise, TN. Principles of psychosomatic assessment. Adv Psychosom Med 2012;32:118.Google Scholar
79. Van Os, J. Solutions for patients depend on whether we can bridge the divide between social and natural science research approaches in the area of mental health. Rev Psiquiatr Salud Ment 2012;5:135138.Google Scholar
80. Ellenberger, HF. The Discovery of the Unconscious: The History and Evolution of Dynamic Psychiatry. New York, NY: Basic Books, 1981.Google Scholar
81. Sadler, JZ. Psychiatric molecular genetics and the ethics of social promises. J Bioeth Inq 2011;8:2734.Google Scholar
82. Muglia, P. From genes to therapeutic targets for psychiatric disorders – what to expect? Curr Opin Pharmacol 2011;11:563571.Google Scholar
83. Insel, TR, Landis, SC, Collins, FS. Research priorities. The NIH BRAIN initiative. Science 2013;340:687688.Google Scholar
84. Borgwardt, S, Radua, J, Mechelli, A et al. Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers. Behav Brain Funct 2012;8:46.Google Scholar
85. Poo, MM. Whereto the mega brain projects? Natl Science Rev 2014;1:1214.Google Scholar
Figure 0

Table 1 Biographical quotes by Jaspers

Figure 1

Table 2 Jaspers’ quotes criticising other psychiatrists

Figure 2

Table 3 Déjà vu: early 20th (based on General Psychopathology) and early 21st century psychiatry

Figure 3

Table 4 Biographical quotes by author

Figure 4

Table 5 Recommendations for current clinicians and the training of future psychiatrists